12:00 AM
 | 
May 06, 2002
 |  BioCentury  |  Finance

Cancer values

Cancer values

Company 5/3 cls 5/3 mkt cap (M) Lead cancer status
Abgenix $13.10 $1,138.4 Multiple Ph II trials ongoing
OSI $30.60

Read the full 162 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >